Skip to main content
Erschienen in: Endocrine 2/2011

01.10.2011 | Original Article

Glycemic control and pregnancy outcomes in women with type 2 diabetes from Poland. The impact of pregnancy planning and a comparison with type 1 diabetes subjects

verfasst von: Katarzyna Cyganek, Alicja Hebda-Szydlo, Jan Skupien, Barbara Katra, Izabela Janas, Alicja Borodako, Irena Kaim, Tomasz Klupa, Alfred Reron, Maciej T. Malecki

Erschienen in: Endocrine | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

The number of pregnancies complicated by type 2 diabetes mellitus (T2DM) is growing; however, their clinical characteristics remain incomplete. We aimed to assess clinical characteristics, glycemic control, and selected pregnancy outcomes in pregestational T2DM from Poland and to compare them with those of T1DM. We analyzed 415 consecutive singleton pregnancies; among them, there were 70 women with T2DM and 345 with T1DM. As compared to T1DM patients, women with T2DM were older (mean age 33.1 years vs. 27.8, respectively), heavier before pregnancy (mean BMI 30.8 kg/m² vs. 23.9), and had a shorter duration of diabetes (mean 3.3 years vs. 11.4); ( P < 0.0001 for all comparisons). The gestational age at the first visit was higher in T2DM (mean 11.4 weeks vs. 8.6; P = 0.0004). Nevertheless, they had better glycemic control in the first trimester (mean HbA1c 6.2% vs. 7.0; P = 0.003); in subsequent months, the differences in HbA1c were no longer significant. T2DM women gained less weight during pregnancy (mean 9.9 kgs vs. 14.1; P < 0.0001). The proportion of miscarriages (10.0 vs. 7.3%; P = 0.32), preterm deliveries (12.7 vs. 17.8%; P = 0.32), combined infant deaths, and congenital malformations were similar in both groups (9.5 vs. 8.8%; P = 0.4) as was the frequency of caesarean sections (58.7 vs. 64.1%; P = 0.30). Macrosomic babies were more than twice less frequent in T2DM and the difference reached borderline significance (7.9 vs. 17.5%, P = 0.07). Pregnancy planning in T2DM had a significant impact on HbA1c in the first trimester (5.7 vs. 6.4% in the planning vs. the not planning group, P = 0.02); the difference was not significant in the second and third trimester. T2DM women had better glycemic control in the first trimester than T1DM subjects and gained less weight during pregnancy. This could have been the reason for the slightly lower number of macrosomic babies but did not affect other outcomes. In T2DM, pregnancy planning had a beneficial glycemic effect in the first trimester.
Literatur
1.
Zurück zum Zitat A.H. Mokdad, E.S. Ford, B.A. Bowman, Diabetes trends in the U.S.: 1990–1998. Diabetes Care 23, 1278–1283 (2000)PubMedCrossRef A.H. Mokdad, E.S. Ford, B.A. Bowman, Diabetes trends in the U.S.: 1990–1998. Diabetes Care 23, 1278–1283 (2000)PubMedCrossRef
2.
Zurück zum Zitat D.S. Feig, V.A. Palda, Type 2 diabetes in pregnancy: a growing concern. Lancet 359, 1690–1692 (2002)PubMedCrossRef D.S. Feig, V.A. Palda, Type 2 diabetes in pregnancy: a growing concern. Lancet 359, 1690–1692 (2002)PubMedCrossRef
3.
Zurück zum Zitat S. Hotu, B. Carter, P.D. Watson, W.S. Cutfield, T. Cundy, Increasing prevalence of type 2 diabetes in adolescents. J. Paediatr. Child Health 40, 201–204 (2004)PubMedCrossRef S. Hotu, B. Carter, P.D. Watson, W.S. Cutfield, T. Cundy, Increasing prevalence of type 2 diabetes in adolescents. J. Paediatr. Child Health 40, 201–204 (2004)PubMedCrossRef
4.
Zurück zum Zitat D.S. Feig, A. Razzaq, K. Sykora, J. Hux, G. Anderson, Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes. A population-based study in Ontario, Canada, 1996–2001. Diabetes Care 29, 232–235 (2006)PubMedCrossRef D.S. Feig, A. Razzaq, K. Sykora, J. Hux, G. Anderson, Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes. A population-based study in Ontario, Canada, 1996–2001. Diabetes Care 29, 232–235 (2006)PubMedCrossRef
5.
Zurück zum Zitat J.L. Kitzmiller, T.A. Buchanan, S. Kjos, C.A. Combs, R.E. Ratner, Pre-conception care of diabetes, congenital malformations and spontaneous abortions. Diabetes Care 19, 514–541 (1996)PubMed J.L. Kitzmiller, T.A. Buchanan, S. Kjos, C.A. Combs, R.E. Ratner, Pre-conception care of diabetes, congenital malformations and spontaneous abortions. Diabetes Care 19, 514–541 (1996)PubMed
6.
Zurück zum Zitat I.F. Casson, C. Clarke, C. Howard, O. McKendrick, S. Pennycook, P. Pharoah, M. Platt, M. Stanisstreet, D. van Velszen, S. Walkinshaw, Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315, 275–278 (1997)PubMed I.F. Casson, C. Clarke, C. Howard, O. McKendrick, S. Pennycook, P. Pharoah, M. Platt, M. Stanisstreet, D. van Velszen, S. Walkinshaw, Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315, 275–278 (1997)PubMed
7.
Zurück zum Zitat DCCT Investigators, Pregnancy outcomes in the diabetes control and complications trial. Am. J. Obstet. Gynecol. 174, 1343–1353 (1996)CrossRef DCCT Investigators, Pregnancy outcomes in the diabetes control and complications trial. Am. J. Obstet. Gynecol. 174, 1343–1353 (1996)CrossRef
8.
Zurück zum Zitat K. Remsberg, R. Mckeown, K. Mcfarland, L. Irwin, Diabetes in pregnancy and cesarean delivery. Diabetes Care 22, 1561–1567 (1999)PubMedCrossRef K. Remsberg, R. Mckeown, K. Mcfarland, L. Irwin, Diabetes in pregnancy and cesarean delivery. Diabetes Care 22, 1561–1567 (1999)PubMedCrossRef
9.
Zurück zum Zitat L. Jovanovic, R. Knopp, H. Kim, W. Cefalu, X. Zhu, Y. Lee, J. Simpson, J. Mills, for the diabetes in early pregnancy study group, Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy evidence for a protective adaptation in diabetes. Diabetes Care 28, 1113–1117 (2005)PubMedCrossRef L. Jovanovic, R. Knopp, H. Kim, W. Cefalu, X. Zhu, Y. Lee, J. Simpson, J. Mills, for the diabetes in early pregnancy study group, Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy evidence for a protective adaptation in diabetes. Diabetes Care 28, 1113–1117 (2005)PubMedCrossRef
10.
Zurück zum Zitat R. Bell, K. Bailey, T. Cresswell, G. Hawthorne, J. Critchley, N. Lewis-Barnede, Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 115, 445–452 (2008)PubMedCrossRef R. Bell, K. Bailey, T. Cresswell, G. Hawthorne, J. Critchley, N. Lewis-Barnede, Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG 115, 445–452 (2008)PubMedCrossRef
11.
Zurück zum Zitat A. Galindo, A. Burguillo, S. Azriel, P. De, la Fuente, Outcome of fetuses in women with pregestational diabetes mellitus. J. Perinat. Med. 34, 323–331 (2006)PubMedCrossRef A. Galindo, A. Burguillo, S. Azriel, P. De, la Fuente, Outcome of fetuses in women with pregestational diabetes mellitus. J. Perinat. Med. 34, 323–331 (2006)PubMedCrossRef
12.
Zurück zum Zitat J.S. Sheffield, E.L. Butler-Koster, B.M. Casey, D.D. McIntire, K.J. Leveno, Maternal diabetes mellitus and infant malformations. Obstet. Gynecol. 100, 925–930 (2002)PubMedCrossRef J.S. Sheffield, E.L. Butler-Koster, B.M. Casey, D.D. McIntire, K.J. Leveno, Maternal diabetes mellitus and infant malformations. Obstet. Gynecol. 100, 925–930 (2002)PubMedCrossRef
13.
Zurück zum Zitat T. Cundy, G. Gamble, K. Townend, P.G. Henley, P. MacPherson, A.B. Roberts, Perinatal mortality in type 2 diabetes mellitus. Diabet. Med. 17, 33–39 (2000)PubMedCrossRef T. Cundy, G. Gamble, K. Townend, P.G. Henley, P. MacPherson, A.B. Roberts, Perinatal mortality in type 2 diabetes mellitus. Diabet. Med. 17, 33–39 (2000)PubMedCrossRef
14.
Zurück zum Zitat K. Ylien, P. Aula, U.-H. Stenman, T. Kesaniemi-Kuokkanen, K. Teramo, Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. BMJ 289, 345–347 (1984)CrossRef K. Ylien, P. Aula, U.-H. Stenman, T. Kesaniemi-Kuokkanen, K. Teramo, Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. BMJ 289, 345–347 (1984)CrossRef
15.
Zurück zum Zitat L. Suhonen, V. Hiilesmaa, K. Teramo, Glycaemic control during early pregnancy and fetal malfomations in women with type 1 diabetes mellitus. Diabetologia 43, 79–84 (2000)PubMedCrossRef L. Suhonen, V. Hiilesmaa, K. Teramo, Glycaemic control during early pregnancy and fetal malfomations in women with type 1 diabetes mellitus. Diabetologia 43, 79–84 (2000)PubMedCrossRef
16.
Zurück zum Zitat G.C. Penney, G. Mair, D.W. Pearson, The relationship between birth weight and maternal glycated hemoglobin (HbA1c) concentration in pregnancies complicated by Type 1 diabetes. Diabet. Med. 20, 162–166 (2003)PubMedCrossRef G.C. Penney, G. Mair, D.W. Pearson, The relationship between birth weight and maternal glycated hemoglobin (HbA1c) concentration in pregnancies complicated by Type 1 diabetes. Diabet. Med. 20, 162–166 (2003)PubMedCrossRef
17.
Zurück zum Zitat H. Murphy, G. Rayman, K. Lewis, S. Kelly, B. Johal, K. Duffield, D. Fowler, P. Campbell, R. Temple, Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 337, 1680–1688 (2008)CrossRef H. Murphy, G. Rayman, K. Lewis, S. Kelly, B. Johal, K. Duffield, D. Fowler, P. Campbell, R. Temple, Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 337, 1680–1688 (2008)CrossRef
18.
Zurück zum Zitat E. Stenninger, A. Lindqvist, J. Ĺman, J. Östlund, E. Schvarcz, Continuous subcutaneous glucose monitoring system in diabetic mothers during labour and postnatal glucose adaptation of their infants. Diabet. Med. 25, 450–454 (2008)PubMedCrossRef E. Stenninger, A. Lindqvist, J. Ĺman, J. Östlund, E. Schvarcz, Continuous subcutaneous glucose monitoring system in diabetic mothers during labour and postnatal glucose adaptation of their infants. Diabet. Med. 25, 450–454 (2008)PubMedCrossRef
19.
Zurück zum Zitat J. Kitzmiller, J. Block, F. Brown, P. Catalano, D. Conway, D. Coustan, E. Gunderson, W. Herman, L. Hoffman, M. Inturrisi, L. Jovanovic, S. Kjos, R. Knopp, M. Montoro, E. Ogata, P. Paramsothy, D. Reader, B. Rosenn, A. Thomas, S. Kirkman, Managing pre-existing diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 31, 1060–1079 (2008)PubMedCrossRef J. Kitzmiller, J. Block, F. Brown, P. Catalano, D. Conway, D. Coustan, E. Gunderson, W. Herman, L. Hoffman, M. Inturrisi, L. Jovanovic, S. Kjos, R. Knopp, M. Montoro, E. Ogata, P. Paramsothy, D. Reader, B. Rosenn, A. Thomas, S. Kirkman, Managing pre-existing diabetes for pregnancy. Summary of evidence and consensus recommendations for care. Diabetes Care 31, 1060–1079 (2008)PubMedCrossRef
20.
Zurück zum Zitat M. Balsells, A. Garcia-Patterson, I. Gich, R. Corcoy, Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J. Clin. Endocrinol. Metab. 94, 4284–4291 (2009)PubMedCrossRef M. Balsells, A. Garcia-Patterson, I. Gich, R. Corcoy, Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J. Clin. Endocrinol. Metab. 94, 4284–4291 (2009)PubMedCrossRef
21.
Zurück zum Zitat K. Cyganek, A. Hebda-Szydlo, B. Katra, J. Skupien, T. Klupa, I. Janas, I. Kaim, J. Sieradzki, A. Reron, M.T. Malecki, Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol. Ther. 12, 41–47 (2010)PubMedCrossRef K. Cyganek, A. Hebda-Szydlo, B. Katra, J. Skupien, T. Klupa, I. Janas, I. Kaim, J. Sieradzki, A. Reron, M.T. Malecki, Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol. Ther. 12, 41–47 (2010)PubMedCrossRef
22.
Zurück zum Zitat K. Keppel, S. Taffel, Pregnancy-related weight gain and retention: implications of the 1990 Institute of Medicine guidelines. Am. J. Public Health 83, 1100–1103 (1993)PubMedCrossRef K. Keppel, S. Taffel, Pregnancy-related weight gain and retention: implications of the 1990 Institute of Medicine guidelines. Am. J. Public Health 83, 1100–1103 (1993)PubMedCrossRef
23.
Zurück zum Zitat H. de Valk, N. van Nieuwaal, G. Visser, Pregnancy outcome in type 2 diabetes mellitus: a retrospective analysis from the Netherlands. Rev Diabet Stud 3, 134–142 (2006)PubMedCrossRef H. de Valk, N. van Nieuwaal, G. Visser, Pregnancy outcome in type 2 diabetes mellitus: a retrospective analysis from the Netherlands. Rev Diabet Stud 3, 134–142 (2006)PubMedCrossRef
24.
Zurück zum Zitat P. Boulot, N. Chabbert-Buffet, C. Ercole, M. Floriot, P. Fontaine, A. Fournier, J.Y. Gillet, H. Gin, S. Grandperret-Vauthier, A.M. Geudj, B. Guionnet, S. Hauguel-de-Mouzon, S. Hieronimus, M. Hoffet, D. Jullien, M.F. Lamotte, V. Lejeune, J. Lepercq, F. Lorenzi, P. Mares, A. Miton, A. Penfornis, B. Pfister, E. Renard, M. Rodier, P. Roth, G.A. Sery, J. Timsit, A.S. Valat, A. Vambergue, O. Verier-Mine, Diabetes and Pregnancy Group, French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 26, 2990–2993 (2003)PubMedCrossRef P. Boulot, N. Chabbert-Buffet, C. Ercole, M. Floriot, P. Fontaine, A. Fournier, J.Y. Gillet, H. Gin, S. Grandperret-Vauthier, A.M. Geudj, B. Guionnet, S. Hauguel-de-Mouzon, S. Hieronimus, M. Hoffet, D. Jullien, M.F. Lamotte, V. Lejeune, J. Lepercq, F. Lorenzi, P. Mares, A. Miton, A. Penfornis, B. Pfister, E. Renard, M. Rodier, P. Roth, G.A. Sery, J. Timsit, A.S. Valat, A. Vambergue, O. Verier-Mine, Diabetes and Pregnancy Group, French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 26, 2990–2993 (2003)PubMedCrossRef
25.
Zurück zum Zitat A. Miller, Diabetes: lessons for midwives. Pract Midwife 8, 4–5 (2005)PubMed A. Miller, Diabetes: lessons for midwives. Pract Midwife 8, 4–5 (2005)PubMed
26.
Zurück zum Zitat T. Clausen, E. Mathiesen, P. Ekbom, E. Hellmuth, T. Mandrup-Poulsen, P. Damm, Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 28, 323–328 (2005)PubMedCrossRef T. Clausen, E. Mathiesen, P. Ekbom, E. Hellmuth, T. Mandrup-Poulsen, P. Damm, Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 28, 323–328 (2005)PubMedCrossRef
27.
Zurück zum Zitat A. Lapolla, M. Dalfra, G. Di Cianni, M. Bonomo, E. Parretti, G. Mello, for the Scientific Committee of the GISOGD Group, A multicenter Italian study on pregnancy outcome in women with diabetes. NMCD 18, 291–297 (2008)PubMed A. Lapolla, M. Dalfra, G. Di Cianni, M. Bonomo, E. Parretti, G. Mello, for the Scientific Committee of the GISOGD Group, A multicenter Italian study on pregnancy outcome in women with diabetes. NMCD 18, 291–297 (2008)PubMed
28.
Zurück zum Zitat M.C. Macintosh, K.M. Fleming, J.A. Bailey, P. Doyle, J. Modder, D. Acolet, Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333, 177 (2006)PubMedCrossRef M.C. Macintosh, K.M. Fleming, J.A. Bailey, P. Doyle, J. Modder, D. Acolet, Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333, 177 (2006)PubMedCrossRef
29.
Zurück zum Zitat E. Verheijen, J. Critchley, D. Whitelaw, D. Tuffnella, Outcomes of pregnancies in women with pre-existing type 1 or type 2 diabetes, in an ethnically mixed population. BJOG 112, 1500–1503 (2005)PubMedCrossRef E. Verheijen, J. Critchley, D. Whitelaw, D. Tuffnella, Outcomes of pregnancies in women with pre-existing type 1 or type 2 diabetes, in an ethnically mixed population. BJOG 112, 1500–1503 (2005)PubMedCrossRef
30.
Zurück zum Zitat N.L. Gonzales-Gonzales, O. Ramirez, J. Mozas, J. Melchor, H. Armas, J.A. Garcia-Hernandez, A. Caballero, M. Hernandez, M.N. Diaz-Gomez, A. Jimenez, J. Parche, J.L. Bartha, Factors influencing pregnancy outcome in women with type 2 versus type 1 diabetes mellitus. Acta Obset. Gynecol. Scand. 87, 43–49 (2008)CrossRef N.L. Gonzales-Gonzales, O. Ramirez, J. Mozas, J. Melchor, H. Armas, J.A. Garcia-Hernandez, A. Caballero, M. Hernandez, M.N. Diaz-Gomez, A. Jimenez, J. Parche, J.L. Bartha, Factors influencing pregnancy outcome in women with type 2 versus type 1 diabetes mellitus. Acta Obset. Gynecol. Scand. 87, 43–49 (2008)CrossRef
31.
Zurück zum Zitat F. Dunne, P. Brydon, K. Smith, H. Gee, Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990–2002. Diabet. Med. 20, 734–738 (2003)PubMedCrossRef F. Dunne, P. Brydon, K. Smith, H. Gee, Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990–2002. Diabet. Med. 20, 734–738 (2003)PubMedCrossRef
32.
Zurück zum Zitat K. Howorka, J. Pumprla, M. Gabriel, A. Feiks, C. Schlusche, C. Nowotny, E. Schober, T. Waldhoer, M. Langer, Normalization of pregnancy outcome in pregestational diabetes through functional insulin treatment and modular out-patient education adapted for pregnancy. Diabet. Med. 18, 965–972 (2001)PubMedCrossRef K. Howorka, J. Pumprla, M. Gabriel, A. Feiks, C. Schlusche, C. Nowotny, E. Schober, T. Waldhoer, M. Langer, Normalization of pregnancy outcome in pregestational diabetes through functional insulin treatment and modular out-patient education adapted for pregnancy. Diabet. Med. 18, 965–972 (2001)PubMedCrossRef
33.
Zurück zum Zitat C. Mulholland, T. Njoroge, P. Mersereau, J. Williams, Comparison of guidelines available in the United States for diagnosis and management of diabetes before, during, and after pregnancy. J. Womens Health 16(6), 790–801 (2007)CrossRef C. Mulholland, T. Njoroge, P. Mersereau, J. Williams, Comparison of guidelines available in the United States for diagnosis and management of diabetes before, during, and after pregnancy. J. Womens Health 16(6), 790–801 (2007)CrossRef
34.
Zurück zum Zitat American Diabetes Association, Standards of medical care in diabetes—2009. Diabetes Care 32(Suppl 1), S13–S61 (2009)CrossRef American Diabetes Association, Standards of medical care in diabetes—2009. Diabetes Care 32(Suppl 1), S13–S61 (2009)CrossRef
35.
Zurück zum Zitat J.D. Walker, NICE guidance on diabetes in pregnancy: management of diabetes, its complications from preconception to the postnatal period. NICE clinical guideline 63. London, March 2008. Diabet. Med. 25(9), 1025–1027 (2008)PubMedCrossRef J.D. Walker, NICE guidance on diabetes in pregnancy: management of diabetes, its complications from preconception to the postnatal period. NICE clinical guideline 63. London, March 2008. Diabet. Med. 25(9), 1025–1027 (2008)PubMedCrossRef
36.
Zurück zum Zitat Polish Diabetes Association, The clinical guidelines in patients with diabetes. Diabetol. Prakt. 11, A38–A43 (2010) Polish Diabetes Association, The clinical guidelines in patients with diabetes. Diabetol. Prakt. 11, A38–A43 (2010)
37.
Zurück zum Zitat N. Holman, N. Lewis-Barned, R. Bell, H. Stephens, J. Modder, J. Gardosi, A. Dornhorst, R. Hillson, B. Young, HR. Murphy, on behalf of the NHS Diabetes in Pregnancy Dataset Development Group, Development and evaluation of a standardized registry for diabetes in pregnancy using data from the Northern, North West and East Anglia regional audits. Diabet. Med. (2011) [Epub ahead of print] N. Holman, N. Lewis-Barned, R. Bell, H. Stephens, J. Modder, J. Gardosi, A. Dornhorst, R. Hillson, B. Young, HR. Murphy, on behalf of the NHS Diabetes in Pregnancy Dataset Development Group, Development and evaluation of a standardized registry for diabetes in pregnancy using data from the Northern, North West and East Anglia regional audits. Diabet. Med. (2011) [Epub ahead of print]
38.
Zurück zum Zitat M. Hod, Y. Yogev, Goals of metabolic management of gestational diabetes. Diabetes Care 30(Suppl 2), S180–S187 (2007)PubMedCrossRef M. Hod, Y. Yogev, Goals of metabolic management of gestational diabetes. Diabetes Care 30(Suppl 2), S180–S187 (2007)PubMedCrossRef
39.
Zurück zum Zitat J. Roland, H. Murphy, V. Ball, J. Northcote-Wright, R. Temple, The pregnancies of women with Type 2 diabetes: poor outcomes but opportunities for improvement. Diabet. Med. 22, 1774–1777 (2005)PubMedCrossRef J. Roland, H. Murphy, V. Ball, J. Northcote-Wright, R. Temple, The pregnancies of women with Type 2 diabetes: poor outcomes but opportunities for improvement. Diabet. Med. 22, 1774–1777 (2005)PubMedCrossRef
40.
Zurück zum Zitat J. Kristensen, M. Vestergaard, K. Wisborg, U. Kesmodel, N. Jørgen, Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG 112, 403–408 (2005)PubMedCrossRef J. Kristensen, M. Vestergaard, K. Wisborg, U. Kesmodel, N. Jørgen, Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG 112, 403–408 (2005)PubMedCrossRef
41.
Zurück zum Zitat H. Ehrenberg, B. Mercer, P. Catalano, The influence of obesity and diabetes on the prevalence of macrosomia. AJOG 191, 964–968 (2004)CrossRef H. Ehrenberg, B. Mercer, P. Catalano, The influence of obesity and diabetes on the prevalence of macrosomia. AJOG 191, 964–968 (2004)CrossRef
42.
Zurück zum Zitat W. Ricart, J. López, J. Mozas, A. Pericot, M.A. Sancho, N. González, M. Balsells, R. Luna, A. Cortázar, P. Navarro, O. Ramírez, B. Flández, L.F. Pallardo, A. Hernández, J. Ampudia, J.M. Fernández-Real, R. Corcoy, Spanish Group for the Study of the Impact of Carpenter, Coustan GDM thresholds, Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia. Diabetologia 48, 1736–1742 (2005)PubMedCrossRef W. Ricart, J. López, J. Mozas, A. Pericot, M.A. Sancho, N. González, M. Balsells, R. Luna, A. Cortázar, P. Navarro, O. Ramírez, B. Flández, L.F. Pallardo, A. Hernández, J. Ampudia, J.M. Fernández-Real, R. Corcoy, Spanish Group for the Study of the Impact of Carpenter, Coustan GDM thresholds, Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia. Diabetologia 48, 1736–1742 (2005)PubMedCrossRef
43.
Zurück zum Zitat I. Thorsdottir, J. Torfadottir, B. Birgisdottir, R. Geirsson, Weight gain in women of normal weight before pregnancy: complications in pregnancy or delivery and birth outcome. Obstet. Gynecol. 99, 799–806 (2002)PubMedCrossRef I. Thorsdottir, J. Torfadottir, B. Birgisdottir, R. Geirsson, Weight gain in women of normal weight before pregnancy: complications in pregnancy or delivery and birth outcome. Obstet. Gynecol. 99, 799–806 (2002)PubMedCrossRef
44.
Zurück zum Zitat J.G. Ray, T.E. O’Brien, W.S. Chan, Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q. J. Med. 94, 435–444 (2001)CrossRef J.G. Ray, T.E. O’Brien, W.S. Chan, Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Q. J. Med. 94, 435–444 (2001)CrossRef
45.
Zurück zum Zitat H.R. Murphy, J.M. Roland, T.C. Skinner, D. Simmons, E. Gurnell, N.J. Morrish, S.C. Soo, S. Kelly, B. Lim, J. Randall, S. Thompsett, R.C. Temple, Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care 33(12), 2514–2520 (2010)PubMedCrossRef H.R. Murphy, J.M. Roland, T.C. Skinner, D. Simmons, E. Gurnell, N.J. Morrish, S.C. Soo, S. Kelly, B. Lim, J. Randall, S. Thompsett, R.C. Temple, Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care 33(12), 2514–2520 (2010)PubMedCrossRef
46.
Zurück zum Zitat D. Farrar, D.J. Tuffnell, J. West, Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst. Rev. 3, 89–94 (2007) D. Farrar, D.J. Tuffnell, J. West, Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst. Rev. 3, 89–94 (2007)
47.
Zurück zum Zitat M.A. Mondestin, C.V. Ananth, J.C. Smulian, A.M. Vintzileos, Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. Am. J. Obstet. Gynecol. 187, 922–926 (2002)PubMedCrossRef M.A. Mondestin, C.V. Ananth, J.C. Smulian, A.M. Vintzileos, Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. Am. J. Obstet. Gynecol. 187, 922–926 (2002)PubMedCrossRef
48.
Zurück zum Zitat A.R. Humphrey, D.J. McCarty, I.R. Mackay, M.J. Rowley, T. Dwyer, P. Zimmet, Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus. Diabet. Med. 15, 113–119 (1998)PubMedCrossRef A.R. Humphrey, D.J. McCarty, I.R. Mackay, M.J. Rowley, T. Dwyer, P. Zimmet, Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus. Diabet. Med. 15, 113–119 (1998)PubMedCrossRef
Metadaten
Titel
Glycemic control and pregnancy outcomes in women with type 2 diabetes from Poland. The impact of pregnancy planning and a comparison with type 1 diabetes subjects
verfasst von
Katarzyna Cyganek
Alicja Hebda-Szydlo
Jan Skupien
Barbara Katra
Izabela Janas
Alicja Borodako
Irena Kaim
Tomasz Klupa
Alfred Reron
Maciej T. Malecki
Publikationsdatum
01.10.2011
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2011
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9475-0

Weitere Artikel der Ausgabe 2/2011

Endocrine 2/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.